UPDATE: Gabelli Starts Bristol-Myers Squibb Co. CVR (BMY-R) at Buy on Attractive Risk/Rward
Tweet Send to a Friend
(Updated - November 27, 2019 5:06 AM EST)
(update comment)Gabelli analyst Kevin Kedra initiates coverage on Bristol-Myers Squibb Co ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(update comment)Gabelli analyst Kevin Kedra initiates coverage on Bristol-Myers Squibb Co ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
